Zhaorui Lian

Author PubWeight™ 15.22^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Genetic mechanisms of hepatocarcinogenesis.	Oncogene	2002	2.21
2	Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?	Cancer Res	2011	1.33
3	Role of miR-148a in hepatitis B associated hepatocellular carcinoma.	PLoS One	2012	1.15
4	Early molecular and genetic determinants of primary liver malignancy.	Surg Clin North Am	2004	1.08
5	Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.	Neoplasia	2002	1.06
6	Enhanced cell survival of gastric cancer cells by a novel gene URG4.	Neoplasia	2006	1.03
7	The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation.	Mol Cell Biol	2011	0.94
8	URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway.	J Cell Mol Med	2008	0.89
9	Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.	Cancer Lett	2009	0.86
10	The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis.	Pathology	2009	0.85
11	The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin.	J Gen Virol	2007	0.83
12	Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis.	Front Biosci	2005	0.81
13	The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.	Mol Cell Biol	2013	0.81
14	Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma.	Int J Cancer	2010	0.80
15	Preparation and characterization of a specific monoclonal antibody against a new gene product: URG11.	Hybridoma (Larchmt)	2006	0.79